Alzheimer’s model mice showed changes without brain plaques
Lacking the immune-signaling protein interleukin-6 partly eased several changes in young and aged mice, particularly females.
Limit: Brain amyloid below detection limits could still contribute to the behavioral and cognitive changes
Edited by Boris Djordjevic · AgingResearch.News
An animal experiment in young and aged male and female Tg2576 mice tested the effects of lacking interleukin-6, an immune-signaling protein, throughout the body. These mice overproduce a protein linked to Alzheimer’s disease.
In this cohort, Tg2576 mice had reduced survival and body weight. Changes in behavior and performance on learning and memory tests varied with age and sex. Lacking interleukin-6 partly eased several of these changes, particularly in females. Blood levels of two forms of amyloid-beta, a protein fragment that can form plaques, were higher. Yet neither form was detectable in the brain. Brain plaques were also absent, unlike in plaque-positive control mice. The authors concluded that changes associated with protein overproduction could occur without detectable amyloid buildup in the brain.
Why it matters
Brain inflammation is implicated in Alzheimer’s disease. This experiment addressed how immune signaling may shape disease-related changes beyond amyloid plaque buildup.
Caveats
The findings came from a specific mouse cohort without detectable brain amyloid, not people with Alzheimer’s disease. The abstract does not quantify the partial improvements.
The paper
Universitat Autònoma de Barcelona
Cells, Oct 22, 2026, Open access, CC BY
